Return
Company Page
Metabolize
Founders
Metabolize is a nutraceutical startup developing metabolite-based solutions to address weight rebound after GLP-1 drug therapy. Backed by SOSV and IndieBio, the company holds an exclusive worldwide license from Stanford University for two naturally occurring metabolites (X-Phe and NAT) that suppress appetite and support lean muscle mass without the side effects associated with GLP-1 medications. Its lead products, NatLean and MetaPair, are designed as over-the-counter dietary supplements targeting the rapidly growing post-GLP-1 consumer health market.
Company Founded in 2024
Healthtech & Biotech